Rama Phosphates Limited's (NSE:RAMAPHO) CEO Compensation Is Looking A Bit Stretched At The Moment

Advertisement

Key Insights

  • Rama Phosphates to hold its Annual General Meeting on 13th of August
  • Total pay for CEO Haresh Ramsinghani includes ₹16.6m salary
  • The total compensation is 225% higher than the average for the industry
  • Rama Phosphates' total shareholder return over the past three years was 11% while its EPS was down 25% over the past three years

Performance at Rama Phosphates Limited (NSE:RAMAPHO) has been reasonably good and CEO Haresh Ramsinghani has done a decent job of steering the company in the right direction. As shareholders go into the upcoming AGM on 13th of August, CEO compensation will probably not be their focus, but rather the steps management will take to continue the growth momentum. However, some shareholders may still want to keep CEO compensation within reason.

See our latest analysis for Rama Phosphates

Comparing Rama Phosphates Limited's CEO Compensation With The Industry

According to our data, Rama Phosphates Limited has a market capitalization of ₹5.3b, and paid its CEO total annual compensation worth ₹20m over the year to March 2025. Notably, that's an increase of 27% over the year before. We note that the salary portion, which stands at ₹16.6m constitutes the majority of total compensation received by the CEO.

For comparison, other companies in the Indian Chemicals industry with market capitalizations below ₹18b, reported a median total CEO compensation of ₹6.0m. This suggests that Haresh Ramsinghani is paid more than the median for the industry.

Component20252024Proportion (2025)
Salary₹17m₹12m85%
Other₹2.9m₹3.6m15%
Total Compensation₹20m ₹15m100%

On an industry level, around 85% of total compensation represents salary and 15% is other remuneration. Although there is a difference in how total compensation is set, Rama Phosphates more or less reflects the market in terms of setting the salary. If total compensation veers towards salary, it suggests that the variable portion - which is generally tied to performance, is lower.

ceo-compensation
NSEI:RAMAPHO CEO Compensation August 7th 2025

Rama Phosphates Limited's Growth

Rama Phosphates Limited has reduced its earnings per share by 25% a year over the last three years. It achieved revenue growth of 24% over the last year.

Investors would be a bit wary of companies that have lower EPS On the other hand, the strong revenue growth suggests the business is growing. It's hard to reach a conclusion about business performance right now. This may be one to watch. Although we don't have analyst forecasts, you might want to assess this data-rich visualization of earnings, revenue and cash flow.

Has Rama Phosphates Limited Been A Good Investment?

Rama Phosphates Limited has served shareholders reasonably well, with a total return of 11% over three years. But they probably wouldn't be so happy as to think the CEO should be paid more than is normal, for companies around this size.

In Summary...

Although the company has performed relatively well, we still think there are some areas that could be improved. EPS growth is still weak, and until that picks up, shareholders may find it hard to approve a pay rise for the CEO, since they are already paid above the average in their industry.

CEO compensation is an important area to keep your eyes on, but we've also need to pay attention to other attributes of the company. We identified 2 warning signs for Rama Phosphates (1 is a bit unpleasant!) that you should be aware of before investing here.

Arguably, business quality is much more important than CEO compensation levels. So check out this free list of interesting companies that have HIGH return on equity and low debt.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About NSEI:RAMAPHO

Rama Phosphates

Manufactures and sales phosphatic fertilizers, chemicals, soya, and micronutrients in India.

Proven track record with adequate balance sheet.

Advertisement

Weekly Picks

LO
Lou_Basenese
CUE logo
Lou_Basenese on Cue Biopharma ·

Cue Biopharma (NASDAQ: CUE): The Scientist Behind Xolair Just Gave Cue a Next-Generation Shot at the Same Multi-Billion-Dollar Market

Fair Value:US$7057.7% undervalued
8 users have followed this narrative
0 users have commented on this narrative
3 users have liked this narrative
HE
HedgeY
ASTS logo
HedgeY on AST SpaceMobile ·

AST SpaceMobile: The Boldest Direct-to-Cell Bet in Public Markets

Fair Value:US$17036.9% undervalued
33 users have followed this narrative
0 users have commented on this narrative
10 users have liked this narrative
FU
ONTO logo
FundamentalFlow on Onto Innovation ·

Onto Innovation: The Advanced Packaging Chokepoint 51.3% undervalued intrinsic discount

Fair Value:US$38027.7% undervalued
23 users have followed this narrative
0 users have commented on this narrative
6 users have liked this narrative
MA
martinarauz
NU logo
martinarauz on Nu Holdings ·

Investment Analysis (May 2026)

Fair Value:US$22.7446.7% undervalued
55 users have followed this narrative
0 users have commented on this narrative
14 users have liked this narrative

Updated Narratives

IM
Imthetxarbi
SLP logo
Imthetxarbi on Sylvania Platinum ·

A Debt-Free PGM Producer Trading at 2x EBITDA With a 10% Dividend Yield Nobody Is Talking About

Fair Value:UK£1.7948.0% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
MI
Miracleworker
DEC logo
Miracleworker on Diversified Energy ·

DEC.L: Dip-Buying Opp, 8%+ Div & 57-100% Potential Gain Over 12 Months

Fair Value:UK£10.460% overvalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
IM
Imthetxarbi
WOSG logo
Imthetxarbi on Watches of Switzerland Group ·

A Compelling Compounder at a Retailer's Multiple

Fair Value:UK£1134.8% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

GO
QS logo
GoldenSands on QuantumScape ·

QuantumScape: A Mispriced Deep‑Tech Inflection Point With Multi‑Billion‑Dollar Optionality

Fair Value:US$8589.3% undervalued
124 users have followed this narrative
3 users have commented on this narrative
36 users have liked this narrative
CL
Clive_Thompson
TTWO logo
Clive_Thompson on Take-Two Interactive Software ·

Take-Two Interactive: The Calm Before the Storm NASDAQ: TTWO Last Price: $242.41 Date: May 15, 2026

Fair Value:US$276.9721.8% undervalued
56 users have followed this narrative
0 users have commented on this narrative
14 users have liked this narrative
NI
niteco
HON logo
niteco on Honeywell International ·

Honeywell - The Demand-Side of the AI Infrastructure

Fair Value:US$320.1932.0% undervalued
46 users have followed this narrative
0 users have commented on this narrative
19 users have liked this narrative